The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Hematopoietic prostaglandin D2synthase controls the onset and resolution of acute inflammation through PGD2and 15-deoxyΔ12–14PGJ2
Open accessAbstract
Hematopoietic prostaglandin D 2 synthase (hPGD 2 S) metabolizes cyclooxygenase (COX)-derived PGH 2 to PGD 2 and 15-deoxyΔ 12–14 PGJ 2(15d-PGJ 2). Unlike COX, the role of hPGD 2 S in host defense is ambiguous. PGD 2 can be either pro- or antiinflammatory depending on disease etiology, whereas the existence of 15d-PGJ 2 and its relevance to pathophysiology remain controversial. Herein, studies on hPGD 2 S KO mice reveal that 15d-PGJ 2 is synthesized in a self-resolving peritonitis, detected by using liquid chromatography–tandem MS. Together with PGD 2 working on its DP1 receptor, 15d-PGJ 2 controls the balance of pro- vs. antiinflammatory cytokines that regulate leukocyte influx and monocyte-derived macrophage efflux from the inflamed peritoneal cavity to draining lymph nodes leading to resolution. Specifically, inflammation in hPGD 2 S KOs is more severe during the onset phase arising from a substantial cytokine imbalance resulting in enhanced polymorphonuclear leukocyte and monocyte trafficking. Moreover, resolution is impaired, characterized by macrophage and surprisingly lymphocyte accumulation. Data from this work place hPGD 2 S at the center of controlling the onset and the resolution of acute inflammation where it acts as a crucial checkpoint controller of cytokine/chemokine synthesis as well as leukocyte influx and efflux. Here, we provide definitive proof that 15d-PGJ 2 is synthesized during mammalian inflammatory responses, and we highlight DP1 receptor activation as a potential antiinflammatory strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citationResolvin E1 and protectin D1 activate inflammation-resolution programmes
Schwab, J. M., Chiang, N., Arita, M., & Serhan, C. N. (2007) · Nature · doi:10.1038/nature05877 · Cited by 1,184
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Self-citationHaas, K. M., Poe, J. C., Steeber, D. A., & Tedder, T. F. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.011 · Cited by 628
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006 · Cited by 576
Cyclopentenone prostaglandins: New insights on biological activities and cellular targets
Straus, D. S., & Glass, C. K. (2001) · Medicinal Research Reviews · doi:10.1002/med.1006.abs · Cited by 520
Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martinez-Losa, M., Walker, T. R., Duffin, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1468 · Cited by 509
Bellingan, G. J., Caldwell, H., Howie, S. E., Dransfield, I., & Haslett, C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.6.2577 · Cited by 378
Self-citation15d-PGJ2: The anti-inflammatory prostaglandin?
Scher, J. U., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.09.008 · Cited by 348
Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the ligation of PPARγ
Bell-Parikh, L. C., Ide, T., Lawson, J. A., McNamara, P., Reilly, M., & FitzGerald, G. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18012 · Cited by 341
Wallace, J. L., Bak, A., McKnight, W., Asfaha, S., Sharkey, K. A., & MacNaughton, W. K. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70370-1 · Cited by 336
Ajuebor, M. N., Das, A. M., Virág, L., Flower, R. J., Szabó, C., & Perretti, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1685 · Cited by 300
Prostaglandin D synthase: Structure and function
(2000) · Vitamins & Hormones · doi:10.1016/s0083-6729(00)58022-4 · Cited by 299
Cernuda-Morollón, E., Pineda-Molina, E., Cañada, F. J., & Pérez-Sala, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104518200 · Cited by 292
Cailhier, J. F., Partolina, M., Vuthoori, S., Wu, S., Ko, K., Watson, S., Savill, J., Hughes, J., & Lang, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2336 · Cited by 247
Liu, M. C., Bleecker, E. R., Lichtenstein, L. M., Kagey-Sobotka, A., Niv, Y., McLemore, T. L., Permutt, S., Proud, D., & Hubbard, W. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.1.126 · Cited by 247
Fujitani, Y., Kanaoka, Y., Aritake, K., Uodome, N., Okazaki-Hatake, K., & Urade, Y. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.443 · Cited by 225
Hammad, H., Jan de Heer, H., Soullie, T., Hoogsteden, H. C., Trottein, F., & Lambrecht, B. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.3936 · Cited by 194
Hammad, H., Kool, M., Soullié, T., Narumiya, S., Trottein, F., Hoogsteden, H. C., & Lambrecht, B. N. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061196 · Cited by 189
A novel role for phospholipase A 2 isoforms in the checkpoint control of acute inflammation
Gilroy, D. W., Newson, J., Sawmynaden, P., Willoughby, D. A., & Croxtall, J. D. (2004) · The FASEB Journal · doi:10.1096/fj.03-0837com · Cited by 174
Self-citationGilroy, D. W., Colville‐Nash, P., McMaster, S. K., Sawatzky, D. A., Willoughby, D. A., & Lawrence, T. (2003) · The FASEB Journal · doi:10.1096/fj.02-1162fje · Cited by 163
Self-citationTrivedi, S. G., Newson, J., Rajakariar, R., Jacques, T. S., Hannon, R., Kanaoka, Y., Eguchi, N., Colville‐Nash, P., & Gilroy, D. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507175103 · Cited by 150
Self-citationMolecular Basis for the Direct Inhibition of AP-1 DNA Binding by 15-Deoxy-Δ12,14-prostaglandin J2
Pérez‐Sala, D., Cernuda‐Morollón, E., & Cañada, F. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309409200 · Cited by 147
Bellingan, G. J., Xu, P., Cooksley, H., Cauldwell, H., Shock, A., Bottoms, S. E., Haslett, C., Mutsaers, S. E., & Laurent, G. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011794 · Cited by 131
Self-citationMandal, A. K., Zhang, Z., Ray, R., Choi, M. S., Chowdhury, B., Pattabiraman, N., & Mukherjee, A. B. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031666 · Cited by 103
Cyclopentenone: a special moiety for anticancer drug design
Conti, M. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000231471.54288.00 · Cited by 58
Bickley, J. F., Ciucci, A., Evans, P., Roberts, S. M., Ross, N. C., & Santoro, M. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.061 · Cited by 33
Morris, T., Rajakariar, R., Stables, M. J., & Gilroy, D. W. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.001 · Cited by 9
Self-citation
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
Resolution of inflammation: a new therapeutic frontier
Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937
Self-citationProresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
Self-citation
Metadata
- Authors
- Rajakariar, R., Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., Fitzgerald, D., Yaqoob, M. M., & Gilroy, D. W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-12-26
- Volume
- 104
- Issue
- 52
- Pages
- 20979-20984
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2162311264
- Cited by
- 253
- References
- 30
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.